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Results: Primary PTCA Thrombolysis
(l-year follow-up) (N ~ 152) IN = 166) P
Recurrent ischemia 12(8%) 54(33%) <0.0001
Recurrent MI 4(3%) 16(10%) <0.025
Mortality 7(5%) 4(2%) ns
Reocclusion rate 7(5%) 58 (35%) <0.0001
Mean diam, stenosis angio 1 27 ± 15% 56 ± 12% <0.0001
Mean diam. stenosis angio 2 35 ± 22% 68 ± 28% <0.0001
without reocclusion 31 ± 22% 48 ± 15% <0.0001
PTCA t-PA
Group A Group B Group A Group B
Time (mins) (n ~ 36) (n ~ 159) In ~ 38) (n ~ 162)
chest pain onset to randomization 211 ± 129 173± 116* 258 ± 179 183± 139t
randomization to t-PA bolus N/A N/A 34 ± 25 31 ± 22
randomization to cath lab arrival 43 ± 20 39 ± 18 N/A N/A
cath lab arrival to first angiogram 21 ± 9 20 ± 11 N/A N/A
first angiogram to reperfusion 19 ± 14 20 ± 24 N/A N/A
Hospital events
PTCA success 91.7% 94.3% N/A N/A
Death 5.6% 1,9% 7,9% 6.2%
Death or reinfarction 13.4% 3.1%§ 18.4% 105%£
Recurrent ischemia 16.7% 88%£ 34.2% 26.5%
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Is Primary Angioplasty Less Effective in Patients with
Acute Myocardial Infarction Presenting in the Early
Morning Hours?
Gregg W. Stone, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald Rothbaum,
James O'Keefe, Paul Overlie, Brian Donohue, Sylvia Puchrowicz, William W. O'Neill
£1 Camino Hospital, Mountain View- CA; William Beaumont Hospital, Royal Oak, MI
Concern has been expressed that delays in physician and cath lab mobiliza-
tion may adversely affect the feasibility and outcome of a primary angioplasty
strategy in pts with acute MI presenting in the early morning hours. In the
PAMI Trial, 395 pts within 12 hours onset of MI were prospectively random-
ized to t-PA (n = 200) vs. primary PTCA (n = 195). Demographic characteris-
tics were similar between pts presenting between 12 MN and 6 AM (Group
A) and 6 AM to 12 MN (Group B). Outcomes appear below:
Conclusion: Not only lesion diameter stenosis at first and second angiog-
raphy, but also reocclusion rate is much better with primary PTCA than with
thrombolysis. Apart from the very high reperfusion rate by PTCA for acute MI,
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Prehospital thrombolysis preserves LV function, but its impact on long-term
outcome has not yet been reported. We followed for 2-7 years, 362 patients
(pts) who received IV thrombolysis since prehospital strategy was started in
Jerusalem. CHF as judged by clinical symptoms and exercise performance
were compared between 68 pts who received prehospital streptokinase, at
1.2 ± 0.6 hours of chest pain onset (group II and 294 pts with in-hospital lysis
after 2.2 ± 1.0 hours (group II).
The difference in LV function measured at 1 week contrast ventriculogra-
phy was small - Group 1- EF 58 ± 15% vs Group II - 55 ± 14%, but a
striking and significant change was observed in CHF disability (NYHA Grade
II-IV) prevalence at follow-up.
Prehospital Thrombolysis in Acute MI Prevents
Symptoms of Congestive Heart Failure - A
Long-term Follow-up Study
A. Teddy Weiss, Dan Gilon, Iris Shviro, Dan Sapoznikov, Shimon Rosenheck,
Morris Mosseri, Chaim Lotan, Yoseph Rozenman, Mervyn S. Gotsman Cardiology
Department, Hadassah Hospitals, Jerusalem, Israel
arrival. and either 0 waves or LBBB on the initial ECG, to predict mortality at
28 days and 1 year after MI.
The model was developed in 5781 pts in the MONICA data base (1984--93)
who were <65 yo, seen 1-24 hrs after symptom onset, had an ECG and were
admitted to CCU. The model was then tested in another 1000 pts. Morbidity
and mortality at 28 days and 1 year was then examined in relation to risk
Score.
Results: Overall mortality at 28 days and 1 year was 4.2% and 7.0%. The
modelidentified 60% ofpts <60 yo at very low risk (Score = 0; Mortality 1%
at 28 days and <2% at 1 year), and proved equally sensitive, specific (90%)
and predictive of survival (99%) in the test group. Of the 2562 pts with either
ST elevation or LBBB on the initial ECG, 46% had a Score = O. In these pts
n was not associated with a reduction in mortality (0.9% vs 1.0%) or heart
failure (2.5%) at 28 days. In contrast, in pts with ST elevation or LBBB and a
Score> 0, n was associated with an absolute reduction in mortality at 28
days (4.6% vs 10.6%*) and 1 year (6.1 % vs 16.1 %*); *p < 0.01.
Conclusion: In pts presenting with MI, it is possible to readily identify those
at very low (1 %) risk of death in whom the absolute benefit of n may be out
weighed by the absolute risk of treatment.
Similar significant changes between the two groups were observed for
other complaints: pulmonary edema, orthopnea, paroxysmal nocturnal dys-
pnea, nocturia, peripheral edema, fatigue and angina pectoris.
Thus, time gain through prehospital lysis prevents CHF symptoms and
long-term disability and justifies more extensive use of early thrombolysis.
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Better Vessel Status with Less Reocclusion at 3
Months as Additional Mechanism for Improved
Outcome of Primary Angioplasty for Acute
Myocardial Infarction
Gerrit Veen, Menko Jan de Boer, Felix Zijlstra, Freek WA. Verheugt. Free University
Hospital, Amsterdam, Hospital De Weezenlanden, Zwolle, The Netherlands
Primary angioplasty IPTCA) for acute myocardial infarction (MI) is associated
with improved clinical outcome (less recurrent ischemia and myocardial in-
farction), when compared to thrombolytic therapy. We sought to determine,
whether these differences were related to differences in angiographic out-
come during follow-up.
In the Zwolle-trial primary PTCAwas compared to streptokinase treatment.
However, in the thrombolysis group only a follow-up angiography was per-
formed. Therefore, in these patients (pts) successful reperfusion and reoc-
c1usion rate could not be determined.
In this report we compared quantitative angiographic and clinical follow-
up data of the pts randomized to primary angioplasty in the Zwolle-trial with
data of the APRICOT-trial, in which all pts received thrombolysis. Both study
groups had angiographically documented reperfusion of the infarct-related
artery and underwent a second angiography at 3 months. There were no
important differences in baseline characteristics.
*p < 0.09: t P~ 0.005: §p = 0.008: £p < 0.18. All other p ~ NS
Conclusions. Time to presentation is prolonged in pts with MI in the early
morning hours. No delays occur, however, in cath lab mobilization, PTCA per-
formance or success. Further studies are required to explain the apparently
worse prognosis of pts presenting between 12 MN and 6AM in this trial.
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1778-51 Timing and Mechanism of Death After Direct
Angioplasty for Acute Myocardial Infarction
Bruce Brodie, Thomas Stuckey, Richard Weintraub, Denise Muncy,
Charles Hansen, E. Joseph LeBauer, Thomas Kelly, Jonathan Berry. The Moses H.
Cone Memorial Hospital, Greensboro, N. C.
Of 907 pts with acute myocardial infarction treated with direct angioplasty
(PTCA) from 1984--93, 78 pts (86%1 died within 30 days. Of the 78 pts, 35
(45%) had cardiogenic shock prior to intervention, and an additional 4 (5%)
presented with acute pulmonary edema without shock. Twenty-eight pts
(36%1 died on day 0, 9 (12%) on day 1, and 10 (13%) on day 2. The mecha-
nisms of death were pump failure in 49 (63%), reinfarction in 7 (9%), rupture
in 5 (6.4%), arrhythmia in 3 138), other cardiac causes in 2 (2.6%), and non-
cardiac causes in 12 (15%). Almost all the early deaths (27/28) were due to
pump failure. Of 78 pts who died, 28 (36%) developed hemodynamic deteri-
oration or cardiac arrest immediately after reperfusion and 13 of these died
in the cath lab. Hemodynamic deterioration and cardiac arrest occurred less
often when intra-aortic balloon pumping (IABP) was initiated before PTCA vs
after PTCA or not at all (2/18 (11 %) vs 26/60 143%), P < 0.03).
Conclusion: Mortality after PTCA, like thrombolytic therapy, is the highest
in the first 24 hours, and this is almost always due to pump failure. Unlike
thrombolytic therapy, the incidence of death from rupture and arrhythmias
is relatively low. Early mortality is high partially due to the high incidence of
cardiogenic shock in our population, but some of the early mortality may be
related to hemodynamic deterioration occurring immediately after reperfu-
